SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bin Zhang, Yan Yang, Xiaoting Shi, Wanyu Liao, Min Chen, Alfred Sze-Lok Cheng, Hongli Yan, Cheng Fang, Shu Zhang, Guifang Xu, Shanshan Shen, Shuling Huang, Guangxia Chen, Ying Lv, Tingsheng Ling, Xiaoqi Zhang, Lei Wang, Yuzheng Zhuge, Xiaoping Zou, Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial–mesenchymal transition, Cancer Letters, 2015, 356, 2, 704

    CrossRef

  2. 2
    Rajdeep Das, Philip A. Gregory, Brett G. Hollier, Wayne D. Tilley, Luke A. Selth, Epithelial plasticity in prostate cancer: principles and clinical perspectives, Trends in Molecular Medicine, 2014, 20, 11, 643

    CrossRef

  3. 3
    Micheal O’Cathail, Santhanam Sundar, Re: Michael T. Schweizer, Xian C. Zhou, Hao Wang, et al. The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2014;66:646–52, European Urology, 2014,

    CrossRef

  4. 4
    Krithika Rajagopalan, Ruoyi Qiu, Steven M. Mooney, Shweta Rao, Takumi Shiraishi, Elizabeth Sacho, Hongying Huang, Ellen Shapiro, Keith R. Weninger, Prakash Kulkarni, The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 2, 154

    CrossRef

  5. 5
    D. Le Broc-Ryckewaert, R. Carpentier, E. Lipka, S. Daher, C. Vaccher, D. Betbeder, C. Furman, Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells, International Journal of Pharmaceutics, 2013, 454, 2, 712

    CrossRef